ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents.
Business Model:
Revenue: $2.7B
Employees: 1,001-5,000
Address: 8-2, Kyutaromachi 1-chome
City: Osaka
State: ōsaka prefecture
Zip: 541-8564
Country: JP
ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents on prescription pharmaceuticals. The company focuses on drug discovery leads that are high in certainty and globally competitive. The company was started in 1717 in Dosho-machi, Osaka. Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.
Contact Phone:
Contact Email:
Listed Exchange:
TYO
IPO Date:
6/1/1963
Ticker Symbol:
4528
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2021 | Mediar Therapeutics | Seed Round | - |
5/2021 | Rehab for JAPAN | Series B | 6.4M |
5/2021 | Rehab for JAPAN | Series B | 0 |
3/2021 | Mediar Therapeutics | Seed Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|